Ultragenyx Pharmaceutical Inc (RARE)

07:28 AM

Can Ultragenyx Pharmaceutical Inc. (UP0) stock surprise with quarterly results2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - newser.com

07:28 AM

06:26 AM

Is this a good reentry point in Ultragenyx Pharmaceutical Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - newser.com

06:26 AM

04:39 AM

Pinnacle Associates Ltd. Sells 29,107 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

04:39 AM

04:28 AM

Key metrics from Ultragenyx Pharmaceutical Inc.’s quarterly dataMarket Performance Summary & Proven Capital Preservation Tips - newser.com

04:28 AM

04:07 AM

Chart based analysis of Ultragenyx Pharmaceutical Inc. trends - newser.com

04:07 AM

12:36 PM

Is Ultragenyx Pharmaceutical Inc. stock a top momentum playTrade Entry Summary & High Yield Equity Trading Tips - newser.com

12:36 PM

Nov 02, 2025

Can Ultragenyx Pharmaceutical Inc. stock sustain revenue growthJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com

Nov 02, 2025

Nov 02, 2025

How risky is Ultragenyx Pharmaceutical Inc. stock nowJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com

Nov 02, 2025

Nov 02, 2025

Why Ultragenyx Pharmaceutical Inc. stock appeals to dividend seekersWeekly Profit Analysis & Reliable Breakout Stock Forecasts - newser.com

Nov 02, 2025

Nov 02, 2025

Is Ultragenyx Pharmaceutical Inc. stock attractive after correctionWatch List & Long Hold Capital Preservation Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Is Ultragenyx Pharmaceutical Inc. still worth holding after the dip2025 Retail Activity & Stock Market Timing Techniques - newser.com

Nov 02, 2025

Nov 02, 2025

Y Intercept Hong Kong Ltd Grows Stake in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 02, 2025

Nov 02, 2025

Is Ultragenyx Pharmaceutical Inc. stock dividend yield sustainablePortfolio Performance Report & Long-Term Investment Growth Plans - newser.com

Nov 02, 2025

Nov 01, 2025

Will Ultragenyx Pharmaceutical Inc. see short term momentum2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com

Nov 01, 2025

Nov 01, 2025

Will Ultragenyx Pharmaceutical Inc. stock benefit from upcoming earnings reports2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Earnings visualization tools for Ultragenyx Pharmaceutical Inc.Long Setup & Consistent Growth Stock Picks - newser.com

Nov 01, 2025

Oct 31, 2025

Ultragenyx Pharmaceutical Inc expected to post a loss of $1.23 a shareEarnings Preview - TradingView

Oct 31, 2025

Oct 31, 2025

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Exelixis (EXEL) - The Globe and Mail

Oct 31, 2025

Oct 31, 2025

Ultragenyx doses first subject in study of GTX-102 for angelman syndrome - Clinical Trials Arena

Oct 31, 2025

Oct 31, 2025

What hedge fund moves indicate for Ultragenyx Pharmaceutical Inc. (UP0) stockTreasury Yields & Daily Oversold Stock Bounce Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

Emerald Mutual Fund Advisers Trust Trims Stock Holdings in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Oct 31, 2025

Oct 31, 2025

Can Ultragenyx Pharmaceutical Inc. stock weather global recessionJuly 2025 Market Mood & Verified Technical Trade Signals - newser.com

Oct 31, 2025

Oct 31, 2025

Can Ultragenyx Pharmaceutical Inc. stock deliver sustainable ROE2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com

Oct 31, 2025

Oct 31, 2025

Can Ultragenyx Pharmaceutical Inc. (UP0) stock hold up in economic slowdownMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

Will Ultragenyx Pharmaceutical Inc. stock remain a Wall Street favoriteMarket Performance Summary & Advanced Technical Analysis Signals - newser.com

Oct 31, 2025

Oct 30, 2025

Ultragenyx Pharmaceutical Inc. (RARE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025

Oct 30, 2025

Ultragenyx Begins Dosing in Aurora Study for Angelman Syndrome - TipRanks

Oct 30, 2025

Oct 30, 2025

Ultragenyx (RARE) Begins Aurora Study for Angelman Syndrome Trea - GuruFocus

Oct 30, 2025

Oct 30, 2025

Ultragenyx Pharmaceutical Initiates Aurora Study for Angelman Syndrome - TradingView

Oct 30, 2025

Oct 30, 2025

Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating GTX-102 in Additional Angelman Syndrome Genotypes and Age Groups - The Manila Times

Oct 30, 2025

Oct 30, 2025

Ultragenyx (NASDAQ: RARE) doses 1st patient in GTX-102 study; ~60 across genotypes - Stock Titan

Oct 30, 2025

Oct 30, 2025

Emerald Advisers LLC Sells 54,826 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Oct 30, 2025